Bioavailability of interferon-beta in patients with multiple sclerosis - fishing for the surrogate.
Kieseier
B C
BC
Hartung
H-P
HP
D001682:Biological Availability; D015415:Biomarkers / Q000378:metabolism; D006801:Humans; D007155:Immunologic Factors / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016899:Interferon-beta / Q000493:pharmacokinetics* / Q000627:therapeutic use; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism*; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000378:metabolism
D015415:Biomarkers; D007155:Immunologic Factors; D019715:Tissue Inhibitor of Metalloproteinase-1; D016899:Interferon-beta; D020780:Matrix Metalloproteinase 9